Mechanistically, SGLT2 inhibitors act predominantly through hemodynamic and cardiorenal pathways, whereas GLP-1 receptor agonists exert metabolic, anti-inflammatory, and anti-atherosclerotic effects, providing a rationale for potential complementarity
[1] [3] The mechanism of GLP-1 agonists involves slowing the rate at which food leaves the stomach
BPC-157, 20mg A synthetic pentadecapeptide widely utilized in preclinical research involving cellular signaling, tissue integrity, vascular biology, and cytoprotective pathway investigation
A 1 mL insulin syringe is marked in units
If you started eating better and taking GLP-1 Complete simultaneously, a 12-week log helps tease apart how much benefit comes from the supplement versus the dietary improvements
& Dick, T